drugset / Trial / NCT00306072

Effect of Different Doses of Salacinol Extract on Glycemic and Insulinemic Response in Patients With Type 2 Diabetes

NCT00306072 ↗

Phase 1/2 Completed 82 enrolled Ross Products
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate two levels of the herbal extract Salacia oblonga (salacinol) on postprandial glycemia and insulinemia in patients with Type 2 diabetes after ingestion of a high-carbohydrate control meal.

Timeline

Start
2005-06
Primary completion
—
Completion
2005-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject salacinol Small molecule 240 mg —
Subject salacinol Small molecule 480 mg —